DJ Biogen Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slipped 3.77% to $212.50 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.58% to 7,673.52 and Dow Jones Industrial Average falling 1.18% to 52,786.07.
This was the stock's second consecutive day of losses.
Biogen Inc. closed 5.89% short of its 52-week high of $225.80, which the company reached on September 3rd.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 2.22% to $269.12, Pfizer Inc. $(PFE)$ fell 2.32% to $27.79, and AbbVie Inc. $(ABBV)$ fell 2.99% to $248.78.
Trading volume (617,404) remained 492,227 below its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.